in this issue
Regions :: Western Europe
Wacker Biotech acquires biologics firm in Germany
8:40 AM MST | November 12, 2013 | Natasha Alperowicz
Wacker Biotech, a subsidiary of Wacker Chemie, today announced plans to acquire a production site for bioengineered pharmaceutical proteins (biologics), including the associated business, from BioNet Ventures. The two companies today signed the purchase agreement, which covers Wacker's acquisition of Scil Proteins Production, including the patent portfolio, at the Scil site at Halle, Germany. The transaction is expected to close early next year. Wacker will continue with existing customer partnerships, which Scil Proteins Production already has, and will...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee